CAMKV
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| CaM kinase like vesicle associated | MIM:614993 | Ensembl:ENSG00000164076 | HGNC:HGNC:28788 | PA142672205 | 3p21.31 |
GO terms in CAMKV
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IBA | GO:0005622 | intracellular |
| CC | IEA | GO:0005886 | plasma membrane |
| CC | IEA | GO:0030659 | cytoplasmic vesicle membrane |
| BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | IBA | GO:0018107 | peptidyl-threonine phosphorylation |
| BP | IBA | GO:0035556 | intracellular signal transduction |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IBA | GO:0004683 | calmodulin-dependent protein kinase activity |
| MF | IBA | GO:0005516 | calmodulin binding |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: CAMKV
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CAMKV
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD870 | BRD63610 | 3 |
| iGMDRD187 | BRD9876 | 2 |
| iGMDRD255 | SB225002 | 2 |
| iGMDRD802 | 4-methylfasudil | 4 |
| iGMDRD474 | Avrainvillamide | 4 |
| iGMDRD268 | Cerulenin | 2 |
| iGMDRD524 | ISX-9 | 2 |
| iGMDRD506 | Fedratinib | 2 |
| iGMDRD780 | PP-30 | 1 |
| iGMDRD483 | SCH-529074 | 3 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD546 | BMS-754807 | 2 |
| iGMDRD579 | PF750 | 2 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD425 | ERASTIN | 1 |
| iGMDRD634 | SCHEMBL2608041 | 2 |
| iGMDRD375 | GW-405833 | 4 |
| iGMDRD394 | BX-795 | 2 |
| iGMDRD679 | Bistramide A | 4 |
| iGMDRD280 | CYTOCHALASIN B | 2 |
| iGMDRD152 | 179324-69-7 | 2 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD201 | SKI II | 1 |
| iGMDRD105 | Triptolide | 1 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD192 | CIL56 | 4 |
| iGMDRD103 | SN-38 | 2 |
| iGMDRD158 | NSC141540 | 4 |
| iGMDRD121 | GMX1778 | 3 |
| iGMDRD353 | PD0325901 | 1 |
| iGMDRD367 | Ro 28-1675 | 2 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD882 | CIL41 | 2 |
| iGMDRD79 | Gemcitabine | 4 |
| iGMDRD424 | Tamatinib | 2 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD154 | NSC23766 | 2 |
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
| iGMDRD211 | (1S,3R)-RSL3 | 2 |
| iGMDRD123 | Isoevodiamine | 2 |
| iGMDRD351 | GW843682X | 5 |
| iGMDRD237 | ABT-751 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CAMKV
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.